1-3 of 3
Keywords: Hormone refractory prostate cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Percentage of Positive Biopsy Cores at the Onset of Hormone Therapy for Prostate Cancer: Prognostic Significance

Available to Purchase
Subject Area:
Further Areas
Guillaume Normand, Olivier Celhay, Raphaël Briffaux, Christophe Pirès, Bertrand Doré, Gaëlle Fromont, Jacques Irani
Journal: Urologia Internationalis
Urol Int (2009) 83 (2): 160–165.
https://doi.org/10.1159/000230017
Published Online: 10 September 2009
..., instructions or products referred to in the content or advertisements. Androgen deprivation therapy Hormone refractory prostate cancer Prostate biopsy Prostate biopsy cores, prognostic factors Prostate cancer Urologia Internationalis Original Paper Urol Int 2009;83:160 165 DOI: 10.1159/000230017...
View article titled, Percentage of Positive Biopsy Cores at the Onset of Hormone Therapy for Prostate Cancer: Prognostic Significance
Open the PDF for Percentage of Positive Biopsy Cores at the Onset of Hormone Therapy for Prostate Cancer: Prognostic Significance in another window
Journal Articles

Diethylstilboestrol versus Bicalutamide in Hormone Refractory Prostate Carcinoma: A Prospective Randomized Trial

Available to Purchase
Subject Area:
Further Areas
Ramaswamy Manikandan, Shalom J. Srirangam, Evelyn Pearson, Stephen C.W. Brown, Patrick O’Reilly, Gerald N. Collins
Journal: Urologia Internationalis
Urol Int (2005) 75 (3): 217–221.
https://doi.org/10.1159/000087797
Published Online: 05 October 2005
...Ramaswamy Manikandan; Shalom J. Srirangam; Evelyn Pearson; Stephen C.W. Brown; Patrick O’Reilly; Gerald N. Collins Objective: To compare the efficacy of diethylstilboestrol (DES) with bicalutamide in the treatment of hormone refractory prostate cancer in relation to its effect on prostate-specific...
View article titled, Diethylstilboestrol versus Bicalutamide in Hormone Refractory Prostate Carcinoma: A Prospective Randomized Trial
Open the PDF for Diethylstilboestrol versus Bicalutamide in Hormone Refractory Prostate Carcinoma: A Prospective Randomized Trial in another window
Journal Articles

Loss of Tissue Immunoreactive Androgen Receptor in Prostate Cancer Presenting Initially as an Intracranial Tumor

Available to Purchase
Subject Area:
Further Areas
Hidetoshi Ehara, Muzheng Yang, Takeshi Kawamura, Takashi Deguchi, Yukimichi Kawada, Kuniyasu Shimokawa, Takuji Tanaka
Journal: Urologia Internationalis
Urol Int (1999) 63 (2): 130–132.
https://doi.org/10.1159/000030432
Published Online: 03 December 1999
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hormone refractory prostate cancer...
View article titled, Loss of Tissue Immunoreactive Androgen Receptor in Prostate Cancer Presenting Initially as an Intracranial Tumor
Open the PDF for Loss of Tissue Immunoreactive Androgen Receptor in Prostate Cancer Presenting Initially as an Intracranial Tumor in another window